SlideShare uma empresa Scribd logo
1 de 46
Airborne Particulate
Particle Size:
Statistical Description
Initial Physiological Deposition Site
Airborne Sampling Simulation & Bias
Sampling Devices
PSP and Lung Effects
       Michael A. Jayjock, Ph.D. CIH

                                       1
Particle Size Statistics



                           2
Site of Deposition Depends on Aerodynamic
Particle Size or Aerodynamic Diameter (AD)

• AD is determined by the settling
  velocity of the particle in normal air.
• Any Particle with aerodynamic
  diameter of X falls at the same speed
  as a UNIT DENSITY SPHERE
  with X diameter.
                                         3
Definitions
• Mass Median Aerodynamic Diameter
  (MMAD) – The AD where 50% of the
  aerosol is of larger AD and 50% smaller.
  The AD at the 50th percentile.
• Geometric Standard Deviation (GSD): A
  measure of the width (or dispersion) of the
  distribution. AD at the 84th percentile
  divided by the AD at the 50th percentile

                                                4
Example: Typical In-plant aerosol
     from a “dusty” Plastic Powder
•    MMAD = 10 microns
•    GSD = 2
•    50th percentile AD = 10 microns
•    84th percentile AD = 20 microns
•    16th percentile AD = 5 microns
     Compare to 50% “cut point for respirable
     particulate of 4 or 5 microns – only about
     10% of the airborne K120n is respirable
                                                  5
99.99

                                   99.9
                                                  AEROSOL
Percentage of Mass in Particles



                                    99
                                              MMAD = 10, GSD = 2.0
    Less than Stated Size




                                    90

                                    70
                                    50
                                    30

                                    10                                   MMAD = 10
                                     1

                                    0.1

                                   0.01
                                          1                      10                  100
                                                   Aerodynamic Diameter (microns)

                                                                                      6
Aerosol Distribution MMAD = 10µ and GSD = 2.0




                  Typical for In-Plant Handling
                  “Dusty” Plastic Powder




                                                  7
Definitions/Classifications
• PNOC – airborne particulate not otherwise
  classified
• PSP – poorly soluble airborne particulate
• Lung Overload – dose rate of particulate that
  exceeds the normal rate of clearance leading to an
  even lower rate (or cessation) of clearance and
  secondary toxicity as a result.
• Particulate with Inherent Toxicity – particulate
  that when in contact with pulmonary tissue can
  injure that tissue irrespective of overload.

                                                       8
Initial Physiological
  Deposition Site




                        9
10
11
Airborne
 Sampling
Simulation


             12
BREATHING ZONE SAMPLING
Airborne Mass is measured in the breathing zone of the worker,
which is an imaginary hemisphere of approximately 30 cm,
extending in front of their face and measured from the midpoint of
an imaginary line joining the ears (see diagram below).




                                                                     13
14
THREE MEASUREMENT/SIMULATION CLASSES
       OF AIRBORNE PARTICULATE
              DOSE/EXPOSURE
• INHALABLE: any particle that
 penetrates/deposits past the nose and mouth.
• THORACIC: particles that penetrate/deposit
 anywhere within the lung airways and the gas-
 exchange region
• RESPIRABLE: particles that penetrate/deposit
 exclusively into the gas-exchange region or
 pulmonary region of the deep lung.
                                                 15
INHALABLE MASS
ACGIH operational definition of the proportion of TOTAL
Airborne Aerosol Mass in the breathing zone (BZ) for
any aerodynamic diameter that will be Deposited
anywhere in the respiratory tree including the nose and
mouth.

      SI(d) = 50% x (1 + e-0.06d )

         for 0 < d ≤ 100µm

      where SI(d) = collection efficiency for
      particles with aerodynamic diameter
      d in µm.
                                                          16
ISO TR 7708 Inspirable    ACGIH Inhalable
Particle Aerodynamic
                           Mass Fraction        Particle Mass (IPM)
   Diameter (µm)
                               (%)                       (%)
         0                      100                      100

         1                       -                      97

         2                       -                      94

         5                       -                      87

        10                      73                      77

        20                       -                      65

        30                      52                      58

        40                       -                     54.5

        50                       -                     52.5

        60                      34                       -

       100                      20                      50

       185                       0                 Not defined
                                                                      17
THORACIC DUST
ACGIH Mathematical definition of proportion of
inhalable particulate per AD size that is deposited
anywhere within the lung airways and the gas-
exchange region.




                                                      18
Particle     Thoracic Particle
Aerodynamic     Mass (TPM) (%)
Diameter (µm)
     0                100
     2                 94
     4                 89
     6                80.5
     8                 67
     10                50
     12                35
     14                23
     16                15
     18               9.5
     20                6
     25                2
                                    19
RESPIRABLE PARTICULATE MASS
ACGIH operational definition for proportion of
inhalable particulate per AD size class that will
be deposited deposited in the gas-exchange
region.




                                                    20
Particle          BMRC                 ACGIH
Aerodynamic     Respirable Particle   Respirable Particle
Diameter (µm)    Mass (RPM) (%)        Mass (RPM) (%)
     0                 100                   100

     1                  98                    97

     2                  92                    91

     3                  82                    74

     4                  68                    50

     5                  50                    30

     6                  28                    17

     7                  0                     9

     8                   -                    5

     10                  -                    1
                                                            21
Sampling Devices



                   22
37mm Closed Faced Cassettes
    For “Total” Aerosol




                              23
37mm Cassette showing open-faced option




                                          24
Inlet of an open-faced filter




                                25
37 mm filter in a Cyclone




                            26
27
Inhalable Dust Sampler




                         28
29
30
British Medical Research Council (BMRC)
penetration curve for respirable particles
showing 50% cut point at 5µm.




                                             31
Sampling Bias



                32
33
34
PSP and Lung Effects


                   35
PSP RESPIRABLE
                    vs.
     Non-Respirable Aerosol Particulate
• NON-RESPIRABLE: Insoluble Airborne Particulate
  that is deposited in Upper Respiratory Track (ciliated
  region and above) will go to GI track and be excreted
  quickly.
• RESPIRABLE: Insoluble Airborne particulate that
  penetrates to the deep lungs (pulmonary region) has a
  much longer residence time in the lung; thus, chronic
  exposure is more subject to lung “over-load” effect.

                                                     36
Oberdorster, G: Toxicokinetics and Effects of Fibrous and
 Nonfibrous Particles, Inhalation Toxicology, 14: 29-56, 2002

  Pulmonary Retention Kinetics and Effects of
Poorly Soluble Particulate of Low Toxicity (PSP)

 “…if the deposition rate of the inhaled
 particles exceeds their mechanical clearance
 rate…, the retention half-time is significantly
 increased, reflecting an impaired or
 prolonged alveolar macrophage-mediated
 clearance function with accumulation of lung
 burden.”
                                                            37
Oberdorster (op. cit.)

“Morrow (1988) hypothesized – based on a
thorough evaluation of a number of long-
term inhalation studies with particles in rats –
that the impairment of alveolar macrophage-
mediated clearance is due to a volumetric
overloading of the macrophages resulting
eventually in a failure to actively move
particles toward the mucociliary escalator.”
{emphasis added}

                                              38
Oberdorster (op. cit.)

“He [Morrow] estimated that a phagocytized
particle volume of about 6% of the normal
macrophage volume signals the beginning of
the impaired function, and when 60% of the
normal alveolar macrophage volume is filled
with phagocytized particles its clearance
function will completely cease.”


                                          39
Oberdorster (op. cit.)

“Indeed, plotting the retained particle volume
in lungs of rats after long-term exposure to
different particle types against measured
clearance rates demonstrated the correlation
between clearance rate and retained dust
volume convincingly, as is show in Figure 3.”
{emphasis added}


                                            40
Oberdorster (op. cit.)




                         41
What Specifically Does Morrow Say About the
Data and its Implications for PNOC – WELs ?
• “The results illustrate a progressive decrease in
  alveolar clearance rates once an excessive
  pulmonary burden is attained.”
• “In this context, loss of mobility represents a
  failure of particulate clearance to proceed,
  leading to increased intersitialization of particles
  and to the induction of a host of dysfunctional and
  pathologic conditions of a seemingly generic
  nature.” [emphasis added]
 Morrow, P.E. et al: Chronic Inhalation Study Findings as the basis for
 Proposing a New Occupational Dust Exposure Limit, J of Am. Coll. Tox,
 10, 2, 1991                                                              42
Morrow (op. cit.)

• “…dust overloading represents a serious,
  confounding complication to the toxicological
  assessment, one in which the intrinsic toxicity of
  the test material is either masked or modified by
  the nonspecific effects of dusts on macrophage
  transport.”
• “The foregoing resume of studies indicates that
  overloading effects on dust clearance can be
  expected to occur with any persistently retained
  dust…”


                                                       43
Morrow’s Arguments for a PNOC Respirable Mass
   WEL of less than 1 mg/m3 (Morrow op. cit.)

• For UNIT DENSITY Particles
  (1 mg/m3)(7.2m3/day)(240days/365days) =
                              4.7 mg/day
• Assuming a clearance half life of 200 days (k =
  0.0035/day) THEN                    (0.0035/day)
  (Burden) = 4.7 mg/day
• Lung Burden = 1340 mg/1000g Lung
• Values > 1mg/g lung are associated with overload
  in the Rat.
                                                 44
Continuation of Morrow’s Arguments for a PNOC
   Respirable Mass WEL of less than 1 mg/m3
                  (Morrow op. cit.)

• Breathing rate of 7.2 m3/day is NOT
  conservative.
• Clearance rate assumed for humans is
  typical but it is NOT conservative.
• Xerox Corporation’s HHRC recommended
  and Xerox Corporation implemented an
  internal respirable PNOC limit of 0.4
  mg/m3 in 1990.

                                             45
Morrow Recommendation
Modify any unit density PNOC WEL relative
to the density of the material in question.
For example, Portland Cement has a density
of about 3.15 g/cc. Any PNOC WEL for
these particles should be increased by the
density of the particle; that is, the 8 hour
WEL should be 3.1 times higher than the unit
density WEL of 3.1 mg/m3.
                                           46

Mais conteúdo relacionado

Destaque

NurseReview.Org - Antacids And Controllers Updates (pharmacology for advanced...
NurseReview.Org - Antacids And Controllers Updates (pharmacology for advanced...NurseReview.Org - Antacids And Controllers Updates (pharmacology for advanced...
NurseReview.Org - Antacids And Controllers Updates (pharmacology for advanced...jben501
 
Meten van particle depositie met de SPC Cube van Lighthouse BV
Meten van particle depositie met de SPC Cube van Lighthouse BVMeten van particle depositie met de SPC Cube van Lighthouse BV
Meten van particle depositie met de SPC Cube van Lighthouse BVRon van Dooren
 
Dust and its impact on electronics
Dust and its impact on electronicsDust and its impact on electronics
Dust and its impact on electronicsAtul Mishra
 
Heat Exchangers: Why Efficiency Matters
Heat Exchangers: Why Efficiency MattersHeat Exchangers: Why Efficiency Matters
Heat Exchangers: Why Efficiency MattersZehnder America
 
Process Fans Used in Cement Industry
Process Fans Used in Cement IndustryProcess Fans Used in Cement Industry
Process Fans Used in Cement IndustryNeelRao
 
Chronic bronchitis & emphysema
Chronic bronchitis & emphysemaChronic bronchitis & emphysema
Chronic bronchitis & emphysemaFitriyani Achyar
 
RESPIRATORY SYSTEM: EMPHYSEMA, CHRONIC BRONCHITIS
RESPIRATORY SYSTEM: EMPHYSEMA, CHRONIC BRONCHITISRESPIRATORY SYSTEM: EMPHYSEMA, CHRONIC BRONCHITIS
RESPIRATORY SYSTEM: EMPHYSEMA, CHRONIC BRONCHITISVijay Shankar
 
New engineering materials
New engineering materialsNew engineering materials
New engineering materialsTanuj Parikh
 
Air quality indoor and outdoor
Air quality indoor and outdoorAir quality indoor and outdoor
Air quality indoor and outdoorMonica Blanco
 
Dust collectors and cross contamination
Dust collectors and cross contaminationDust collectors and cross contamination
Dust collectors and cross contaminationNimra Iqbal
 
Contamination Control in the Food Industry
Contamination Control in the Food IndustryContamination Control in the Food Industry
Contamination Control in the Food IndustryNilfiskVacuums
 
Occupational Lung Diseases
Occupational Lung DiseasesOccupational Lung Diseases
Occupational Lung DiseasesDrZahid Khan
 
Occupational lung diseases radiology
Occupational lung diseases radiologyOccupational lung diseases radiology
Occupational lung diseases radiologySatish Naga
 

Destaque (17)

NurseReview.Org - Antacids And Controllers Updates (pharmacology for advanced...
NurseReview.Org - Antacids And Controllers Updates (pharmacology for advanced...NurseReview.Org - Antacids And Controllers Updates (pharmacology for advanced...
NurseReview.Org - Antacids And Controllers Updates (pharmacology for advanced...
 
Meten van particle depositie met de SPC Cube van Lighthouse BV
Meten van particle depositie met de SPC Cube van Lighthouse BVMeten van particle depositie met de SPC Cube van Lighthouse BV
Meten van particle depositie met de SPC Cube van Lighthouse BV
 
Dust and its impact on electronics
Dust and its impact on electronicsDust and its impact on electronics
Dust and its impact on electronics
 
Heat Exchangers: Why Efficiency Matters
Heat Exchangers: Why Efficiency MattersHeat Exchangers: Why Efficiency Matters
Heat Exchangers: Why Efficiency Matters
 
CCIH 2012 Conference, Breakout 4, Molly Krans, Student Project Session, CBPR ...
CCIH 2012 Conference, Breakout 4, Molly Krans, Student Project Session, CBPR ...CCIH 2012 Conference, Breakout 4, Molly Krans, Student Project Session, CBPR ...
CCIH 2012 Conference, Breakout 4, Molly Krans, Student Project Session, CBPR ...
 
Process Fans Used in Cement Industry
Process Fans Used in Cement IndustryProcess Fans Used in Cement Industry
Process Fans Used in Cement Industry
 
Chronic bronchitis & emphysema
Chronic bronchitis & emphysemaChronic bronchitis & emphysema
Chronic bronchitis & emphysema
 
RESPIRATORY SYSTEM: EMPHYSEMA, CHRONIC BRONCHITIS
RESPIRATORY SYSTEM: EMPHYSEMA, CHRONIC BRONCHITISRESPIRATORY SYSTEM: EMPHYSEMA, CHRONIC BRONCHITIS
RESPIRATORY SYSTEM: EMPHYSEMA, CHRONIC BRONCHITIS
 
New engineering materials
New engineering materialsNew engineering materials
New engineering materials
 
Air quality indoor and outdoor
Air quality indoor and outdoorAir quality indoor and outdoor
Air quality indoor and outdoor
 
Dust collectors and cross contamination
Dust collectors and cross contaminationDust collectors and cross contamination
Dust collectors and cross contamination
 
Antacids
AntacidsAntacids
Antacids
 
Antacids
AntacidsAntacids
Antacids
 
Contamination Control in the Food Industry
Contamination Control in the Food IndustryContamination Control in the Food Industry
Contamination Control in the Food Industry
 
ANTACID
ANTACIDANTACID
ANTACID
 
Occupational Lung Diseases
Occupational Lung DiseasesOccupational Lung Diseases
Occupational Lung Diseases
 
Occupational lung diseases radiology
Occupational lung diseases radiologyOccupational lung diseases radiology
Occupational lung diseases radiology
 

Último

maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 

Último (20)

maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 

Particulate seminar

  • 1. Airborne Particulate Particle Size: Statistical Description Initial Physiological Deposition Site Airborne Sampling Simulation & Bias Sampling Devices PSP and Lung Effects Michael A. Jayjock, Ph.D. CIH 1
  • 3. Site of Deposition Depends on Aerodynamic Particle Size or Aerodynamic Diameter (AD) • AD is determined by the settling velocity of the particle in normal air. • Any Particle with aerodynamic diameter of X falls at the same speed as a UNIT DENSITY SPHERE with X diameter. 3
  • 4. Definitions • Mass Median Aerodynamic Diameter (MMAD) – The AD where 50% of the aerosol is of larger AD and 50% smaller. The AD at the 50th percentile. • Geometric Standard Deviation (GSD): A measure of the width (or dispersion) of the distribution. AD at the 84th percentile divided by the AD at the 50th percentile 4
  • 5. Example: Typical In-plant aerosol from a “dusty” Plastic Powder • MMAD = 10 microns • GSD = 2 • 50th percentile AD = 10 microns • 84th percentile AD = 20 microns • 16th percentile AD = 5 microns Compare to 50% “cut point for respirable particulate of 4 or 5 microns – only about 10% of the airborne K120n is respirable 5
  • 6. 99.99 99.9 AEROSOL Percentage of Mass in Particles 99 MMAD = 10, GSD = 2.0 Less than Stated Size 90 70 50 30 10 MMAD = 10 1 0.1 0.01 1 10 100 Aerodynamic Diameter (microns) 6
  • 7. Aerosol Distribution MMAD = 10µ and GSD = 2.0 Typical for In-Plant Handling “Dusty” Plastic Powder 7
  • 8. Definitions/Classifications • PNOC – airborne particulate not otherwise classified • PSP – poorly soluble airborne particulate • Lung Overload – dose rate of particulate that exceeds the normal rate of clearance leading to an even lower rate (or cessation) of clearance and secondary toxicity as a result. • Particulate with Inherent Toxicity – particulate that when in contact with pulmonary tissue can injure that tissue irrespective of overload. 8
  • 9. Initial Physiological Deposition Site 9
  • 10. 10
  • 11. 11
  • 13. BREATHING ZONE SAMPLING Airborne Mass is measured in the breathing zone of the worker, which is an imaginary hemisphere of approximately 30 cm, extending in front of their face and measured from the midpoint of an imaginary line joining the ears (see diagram below). 13
  • 14. 14
  • 15. THREE MEASUREMENT/SIMULATION CLASSES OF AIRBORNE PARTICULATE DOSE/EXPOSURE • INHALABLE: any particle that penetrates/deposits past the nose and mouth. • THORACIC: particles that penetrate/deposit anywhere within the lung airways and the gas- exchange region • RESPIRABLE: particles that penetrate/deposit exclusively into the gas-exchange region or pulmonary region of the deep lung. 15
  • 16. INHALABLE MASS ACGIH operational definition of the proportion of TOTAL Airborne Aerosol Mass in the breathing zone (BZ) for any aerodynamic diameter that will be Deposited anywhere in the respiratory tree including the nose and mouth. SI(d) = 50% x (1 + e-0.06d ) for 0 < d ≤ 100µm where SI(d) = collection efficiency for particles with aerodynamic diameter d in µm. 16
  • 17. ISO TR 7708 Inspirable ACGIH Inhalable Particle Aerodynamic Mass Fraction Particle Mass (IPM) Diameter (µm) (%) (%) 0 100 100 1 - 97 2 - 94 5 - 87 10 73 77 20 - 65 30 52 58 40 - 54.5 50 - 52.5 60 34 - 100 20 50 185 0 Not defined 17
  • 18. THORACIC DUST ACGIH Mathematical definition of proportion of inhalable particulate per AD size that is deposited anywhere within the lung airways and the gas- exchange region. 18
  • 19. Particle Thoracic Particle Aerodynamic Mass (TPM) (%) Diameter (µm) 0 100 2 94 4 89 6 80.5 8 67 10 50 12 35 14 23 16 15 18 9.5 20 6 25 2 19
  • 20. RESPIRABLE PARTICULATE MASS ACGIH operational definition for proportion of inhalable particulate per AD size class that will be deposited deposited in the gas-exchange region. 20
  • 21. Particle BMRC ACGIH Aerodynamic Respirable Particle Respirable Particle Diameter (µm) Mass (RPM) (%) Mass (RPM) (%) 0 100 100 1 98 97 2 92 91 3 82 74 4 68 50 5 50 30 6 28 17 7 0 9 8 - 5 10 - 1 21
  • 23. 37mm Closed Faced Cassettes For “Total” Aerosol 23
  • 24. 37mm Cassette showing open-faced option 24
  • 25. Inlet of an open-faced filter 25
  • 26. 37 mm filter in a Cyclone 26
  • 27. 27
  • 29. 29
  • 30. 30
  • 31. British Medical Research Council (BMRC) penetration curve for respirable particles showing 50% cut point at 5µm. 31
  • 33. 33
  • 34. 34
  • 35. PSP and Lung Effects 35
  • 36. PSP RESPIRABLE vs. Non-Respirable Aerosol Particulate • NON-RESPIRABLE: Insoluble Airborne Particulate that is deposited in Upper Respiratory Track (ciliated region and above) will go to GI track and be excreted quickly. • RESPIRABLE: Insoluble Airborne particulate that penetrates to the deep lungs (pulmonary region) has a much longer residence time in the lung; thus, chronic exposure is more subject to lung “over-load” effect. 36
  • 37. Oberdorster, G: Toxicokinetics and Effects of Fibrous and Nonfibrous Particles, Inhalation Toxicology, 14: 29-56, 2002 Pulmonary Retention Kinetics and Effects of Poorly Soluble Particulate of Low Toxicity (PSP) “…if the deposition rate of the inhaled particles exceeds their mechanical clearance rate…, the retention half-time is significantly increased, reflecting an impaired or prolonged alveolar macrophage-mediated clearance function with accumulation of lung burden.” 37
  • 38. Oberdorster (op. cit.) “Morrow (1988) hypothesized – based on a thorough evaluation of a number of long- term inhalation studies with particles in rats – that the impairment of alveolar macrophage- mediated clearance is due to a volumetric overloading of the macrophages resulting eventually in a failure to actively move particles toward the mucociliary escalator.” {emphasis added} 38
  • 39. Oberdorster (op. cit.) “He [Morrow] estimated that a phagocytized particle volume of about 6% of the normal macrophage volume signals the beginning of the impaired function, and when 60% of the normal alveolar macrophage volume is filled with phagocytized particles its clearance function will completely cease.” 39
  • 40. Oberdorster (op. cit.) “Indeed, plotting the retained particle volume in lungs of rats after long-term exposure to different particle types against measured clearance rates demonstrated the correlation between clearance rate and retained dust volume convincingly, as is show in Figure 3.” {emphasis added} 40
  • 42. What Specifically Does Morrow Say About the Data and its Implications for PNOC – WELs ? • “The results illustrate a progressive decrease in alveolar clearance rates once an excessive pulmonary burden is attained.” • “In this context, loss of mobility represents a failure of particulate clearance to proceed, leading to increased intersitialization of particles and to the induction of a host of dysfunctional and pathologic conditions of a seemingly generic nature.” [emphasis added] Morrow, P.E. et al: Chronic Inhalation Study Findings as the basis for Proposing a New Occupational Dust Exposure Limit, J of Am. Coll. Tox, 10, 2, 1991 42
  • 43. Morrow (op. cit.) • “…dust overloading represents a serious, confounding complication to the toxicological assessment, one in which the intrinsic toxicity of the test material is either masked or modified by the nonspecific effects of dusts on macrophage transport.” • “The foregoing resume of studies indicates that overloading effects on dust clearance can be expected to occur with any persistently retained dust…” 43
  • 44. Morrow’s Arguments for a PNOC Respirable Mass WEL of less than 1 mg/m3 (Morrow op. cit.) • For UNIT DENSITY Particles (1 mg/m3)(7.2m3/day)(240days/365days) = 4.7 mg/day • Assuming a clearance half life of 200 days (k = 0.0035/day) THEN (0.0035/day) (Burden) = 4.7 mg/day • Lung Burden = 1340 mg/1000g Lung • Values > 1mg/g lung are associated with overload in the Rat. 44
  • 45. Continuation of Morrow’s Arguments for a PNOC Respirable Mass WEL of less than 1 mg/m3 (Morrow op. cit.) • Breathing rate of 7.2 m3/day is NOT conservative. • Clearance rate assumed for humans is typical but it is NOT conservative. • Xerox Corporation’s HHRC recommended and Xerox Corporation implemented an internal respirable PNOC limit of 0.4 mg/m3 in 1990. 45
  • 46. Morrow Recommendation Modify any unit density PNOC WEL relative to the density of the material in question. For example, Portland Cement has a density of about 3.15 g/cc. Any PNOC WEL for these particles should be increased by the density of the particle; that is, the 8 hour WEL should be 3.1 times higher than the unit density WEL of 3.1 mg/m3. 46